HALOZYME THERAPEU.DL-,001 revenue breakdown overview

HALOZYME THERAPEU.DL-,001 revenue for the last year amounted to 751.31 M EUR, the most of which — 751.31 M EUR — came from its highest performing source at the moment, Enzymes and Devices, the year earlier bringing 616.79 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought HALOZYME THERAPEU.DL-,001 532.01 M EUR, and the year before that — 409.24 M EUR.